Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 3, 2026, Healthcare Services Group, Inc. (HCSG) has a Wall Street consensus price target of $23.33, based on estimates from 14 covering analysts. With the stock currently trading at $21.77, this represents a potential upside of +7.2%. The company has a market capitalization of $1.67B.
Analyst price targets range from a low of $22.00 to a high of $25.00, representing a 13% spread in expectations. The median target of $23.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 7 analysts rating the stock as a Buy or Strong Buy,5 rating it Hold, and 2 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, HCSG trades at a trailing P/E of 26.9x and forward P/E of 22.5x. Analysts expect EPS to grow +78.7% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $20.16, with bear and bull scenarios of $11.48 and $50.81 respectively. Model confidence stands at 55/100, reflecting moderate uncertainty in projections.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how HCSG stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonThe consensus price target for HCSG is $23.33, close to the current price of $21.77 (7.2% implied move). Based on 14 analyst estimates, the stock appears fairly valued near current levels.
HCSG has a consensus rating of "Buy" based on 14 Wall Street analysts. The rating breakdown is mixed, with 5 Hold ratings making up the largest segment. The consensus 12-month price target of $23.33 implies 7.2% upside from current levels.
HCSG trades at a forward P/E of 22.5386x, representing a moderate valuation. With analysts targeting $23.33 (7.2% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $25 for HCSG, while the most conservative target is $22. The consensus of $23.33 represents the median expectation. Our quantitative valuation model projects a bull case target of $51 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
HCSG is moderately covered, with 14 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 7 have Buy ratings, 5 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month HCSG stock forecast based on 14 Wall Street analysts shows a consensus price target of $23.33, with estimates ranging from $22 (bear case) to $25 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $20, with bear/bull scenarios of $11/$51.
Our quantitative valuation model calculates HCSG's fair value at $20 (base case), with a bear case of $11 and bull case of $51. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 55/100.
HCSG trades at a forward P/E ratio of 22.5x based on next-twelve-months earnings estimates compared to a trailing P/E of 26.9x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
HCSG appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $23.33 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
HCSG analyst price targets range from $22 to $25, a 13% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $23.33 consensus represents the middle ground. Our model's $11-$51 range provides an independent fundamental perspective.